In addition, SUV39H2 shows oncogenic activity, and knockdown of SUV39H2 by specific siRNAs suppresses the growth of cancer cells [25, 26], suggesting that SUV39H2 appears to be an ideal target for the development of anti-cancer therapy. Here, SUV39H2 is linked to cancer.